Back to Search
Start Over
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion
- Source :
- CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET, Oxidative Medicine and Cellular Longevity, Oxidative Medicine and Cellular Longevity, Vol 2015 (2015)
- Publication Year :
- 2015
- Publisher :
- Hindawi Limited, 2015.
-
Abstract
- Edaravone (5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, EDV) is a free-radical scavenger reduces organ ischemic injury. Here we investigated whether the protective effects of EDV in renal ischemia/reperfusion (I/R) injury may be enhanced by an EDV derivative bearing a nitric oxide- (NO-) donor furoxan moiety (NO-EDV). Male Wistar rats were subjected to renal ischemia (45 minutes), followed by reperfusion (6 hours). Administration of either EDV (1.2–6–30 µmol/kg, i.v.) or NO-EDV (0.3–1.2–6 µmol/kg, i.v.) dose-dependently attenuated markers of renal dysfunction (serum urea and creatinine, creatinine clearance, urine flow, urinary N-acetyl-β-D-glucosaminidase, and neutrophil gelatinase-associated lipocalin/lipocalin-2). NO-EDV exerted protective effects in the dose-range 1.2–6 µmol/kg, while a higher dose (30 µmol/kg) was needed to obtain protection by EDV. Both EDV and NO-EDV modulated tissue markers of oxidative stress and lipid peroxidation. NO-EDV, but not EDV, activated endothelial NO synthase (NOS) and blunted I/R-induced upregulation of inducible NOS, secondary to modulation of Akt and NF-κB activation, respectively. Besides NO-EDV administration inhibited I/R-induced IL-1β, IL-18, IL-6, and TNF-α overproduction. Overall, these findings demonstrate that the NO-donor moiety contributes to the protection against early renal I/R injury and suggest that NO-donor EDV codrugs are worthy of additional study as innovative pharmacological tools. Fil: Chiazza, Fausto. Universitã â Di Torino; Italia Fil: Chegaev, Konstantin. Università  Di Torino; Italia Fil: Rogazzo, Mara. Universitã â Di Torino; Italia Fil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas (i); Argentina Fil: Beneti, Elisa. Universita di Torino; Italia Fil: Lazzarato, Loretta. Universita di Torino; Italia Fil: Fruttero, Roberta. Universita di Torino; Italia Fil: Collino, Massimo. Universita di Torino; Italia
- Subjects :
- Male
Aging
Pharmacology
Kidney
Biochemistry
NITRIC OXIDE DONOR
chemistry.chemical_compound
Ischemia
Malondialdehyde
Edaravone
Urea
Oxadiazoles
lcsh:Cytology
Free Radical Scavengers
purl.org/becyt/ford/3.1 [https]
General Medicine
Lipocalins
Medicina Básica
medicine.anatomical_structure
Creatinine
Reperfusion Injury
purl.org/becyt/ford/3 [https]
Research Article
Farmacología y Farmacia
medicine.medical_specialty
CIENCIAS MÉDICAS Y DE LA SALUD
Article Subject
Renal function
Acetylglucosamine
Nitric oxide
Lipocalin-2
Proto-Oncogene Proteins
medicine
Animals
Nitric Oxide Donors
lcsh:QH573-671
Rats, Wistar
Renal ischemia
KIDNEY ISCHEMIA-REPERFUSION
Kidney metabolism
Cell Biology
medicine.disease
Rats
Surgery
Disease Models, Animal
Oxidative Stress
chemistry
Lipid Peroxidation
Proto-Oncogene Proteins c-akt
Reperfusion injury
Antipyrine
Acute-Phase Proteins
Subjects
Details
- ISSN :
- 19420994 and 19420900
- Volume :
- 2015
- Database :
- OpenAIRE
- Journal :
- Oxidative Medicine and Cellular Longevity
- Accession number :
- edsair.doi.dedup.....5069780b90cd9d43a21577eac7cb47ac